Objective: The aim of this group of studies was to determine the relat
ionship between primary nocturnal enuresis and arginine-vasopressin (A
VP) secretion. Methods: The first study compared the 24-hour AVP secre
tion profiles of an enuretic group and a control group. Blood samples
were collected every hour. In the second study, we compared nocturnal
AVP secretion in group A, with low urinary osmotic pressure (UOP) and
large nocturnal urinary volume (NUV), with that of group D, with norma
l UOP and small NUV. The plasma AVP level was measured at 30-min sampl
ing intervals. In the third study, the change in nocturnal AVP secreti
on from before to after treatment was determined. Results: The plasma
AVP level was significantly lower in the enuretic group from 23:00 thr
ough 04:00 h. The mean plasma AVP level was significantly lower in gro
up A than in group D at all points of measurement. The mean nocturnal
AVP level in group A (0.64 +/- 0.23 pg/ml) was lower than that in grou
p D (1.43 +/- 0.72 pg/ml) (p< 0.0001). The mean nocturnal AVP level af
ter treatment was significantly increased, from 0.47 pg/ml before trea
tment to 0.78 pg/ml after treatment (p = 0.01). However, a significant
increase was noted in only 10 cases. Conclusions: These findings sugg
est that decreased nocturnal AVP secretion is one of the causes of bed
-wetting. However, the improvement of bed-wetting was not solely due t
o the increased nocturnal AVP secretion.